POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 53 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $241,300 | -54.4% | 82,637 | -62.8% | 0.00% | -100.0% |
| Q3 2023 | $529,110 | +30.7% | 222,315 | -3.3% | 0.00% | 0.0% |
| Q2 2023 | $404,800 | -23.5% | 230,000 | +33.8% | 0.00% | -50.0% |
| Q1 2023 | $529,283 | +295.0% | 171,845 | +1304.7% | 0.00% | +100.0% |
| Q4 2020 | $134,000 | +34.0% | 12,234 | +8.6% | 0.00% | 0.0% |
| Q3 2020 | $100,000 | – | 11,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $11,445,000 | 1.96% |
| Pentwater Capital Management LP | 4,967,227 | $54,490,000 | 0.66% |
| SECTORAL ASSET MANAGEMENT INC | 838,826 | $9,202,000 | 0.65% |
| Vivo Capital, LLC | 926,447 | $10,163,000 | 0.45% |
| Boxer Capital, LLC | 1,251,055 | $13,724,000 | 0.44% |
| Ikarian Capital, LLC | 250,837 | $2,752,000 | 0.12% |
| Perceptive Advisors | 787,745 | $8,642,000 | 0.09% |
| Rock Springs Capital Management LP | 289,754 | $3,179,000 | 0.07% |
| Regent Investment Management LLC | 20,000 | $219,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,450,268 | $15,909,000 | 0.04% |